← United States · Coverage record
US · SEC FORM 4
Ardent Health, Inc.
ARDT · NYSE · CIK 0001756655 · Healthcare · Medical Care Facilities
INSIDER SIGNAL
2 buyers · 2 purchase transaction lines · $186.4K gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ Purchase activity is becoming less recent
- ✓ Role scores high · most senior buyer: Chief Financial Officer
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth & concentration
Roles in the peak window: Chief Financial Officer, Director. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 50.1
- 50.1
- 50.0
- 50.0
- 49.9
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- +1.2%
- 3M
- +7.8%
- 6M
- +16.6%
- 12M
- -24.4%
Volatility & liquidity
- Volatility
- 51.8%
- Beta
- 0.72
- Avg daily value
- USD 4.8M
Valuation
- Market cap
- USD 1.5B
- P/E
- 19.8×
Fundamentals
- Profit margin
- 2.1%
- ROE
- 10.5%
- Industry
- Medical Care Facilities
Market data
Price data up to: 2026-10-07 · Price source: OpenBB/yfinance · From SEC filings: Profit margin, ROE · Fiscal year ended: 2025-12-31 · From Yahoo Finance: Market cap, P/E · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 4,632,524
- Previous report
- 4,576,550
- Avg daily volume
- 432,626
- Days to cover
- 10.7
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | LUMSDAINE ALFRED | Purchase (P) | Common Stock | 10,000 | USD 8.81 | USD 88,100 | SEC filing ↗ |
| 2026-06-05 | DeMichiei Robert | Purchase (P) | Common Stock | 11,260 | USD 8.73 | USD 98,300 | SEC filing ↗ |
| 2024-11-08 | Webb Robert Thomas | Purchase (P) | Common Stock | 20,000 | USD 16.98 | USD 339,600 | SEC filing ↗ |
Form 4 evidence
31 transaction lines in the latest 365-day window; 84 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Petrovich Stephen C. | Tax withholding (F) | Common Stock | 788 | USD 10.54 | USD 8,306 | SEC filing ↗ |
| 2026-09-25 | LUMSDAINE ALFRED | Tax withholding (F) | Common Stock | 3,389 | USD 10.54 | USD 35,720 | SEC filing ↗ |
| 2026-09-25 | Byers David Raynor | Tax withholding (F) | Common Stock | 524 | USD 10.54 | USD 5,523 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Petrovich Stephen C. | Tax withholding (F) | Common Stock | 788 | USD 10.54 | USD 8,306 | SEC filing ↗ |
| 2026-09-25 | LUMSDAINE ALFRED | Tax withholding (F) | Common Stock | 3,389 | USD 10.54 | USD 35,720 | SEC filing ↗ |
| 2026-09-25 | Byers David Raynor | Tax withholding (F) | Common Stock | 524 | USD 10.54 | USD 5,523 | SEC filing ↗ |
| 2026-07-01 | Caspers Dave | Award / grant (A) | Common Stock | 103,653 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-05 | LUMSDAINE ALFRED | Purchase (P) | Common Stock | 10,000 | USD 8.81 | USD 88,100 | SEC filing ↗ |
| 2026-06-05 | DeMichiei Robert | Purchase (P) | Common Stock | 11,260 | USD 8.73 | USD 98,300 | SEC filing ↗ |
| 2026-04-01 | Webb Robert Thomas | Award / grant (A) | Common Stock | 14,231 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Sotir Mark R | Award / grant (A) | Common Stock | 14,231 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Sen Rahul | Award / grant (A) | Common Stock | 14,231 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Robinson Edmondo | Award / grant (A) | Common Stock | 14,231 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Petrovich Stephen C. | Tax withholding (F) | Common Stock | 1,808 | USD 8.67 | USD 15,675 | SEC filing ↗ |
| 2026-04-01 | Petrovich Stephen C. | Award / grant (A) | Common Stock | 24,904 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | LUMSDAINE ALFRED | Tax withholding (F) | Common Stock | 4,381 | USD 8.67 | USD 37,983 | SEC filing ↗ |
| 2026-04-01 | LUMSDAINE ALFRED | Award / grant (A) | Common Stock | 53,846 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Havdala Ellen | Award / grant (A) | Common Stock | 14,231 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | GOODYEAR WILLIAM M | Award / grant (A) | Common Stock | 14,231 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | DeMichiei Robert | Award / grant (A) | Common Stock | 14,231 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Caspers Dave | Tax withholding (F) | Common Stock | 2,684 | USD 8.67 | USD 23,270 | SEC filing ↗ |
| 2026-04-01 | Caspers Dave | Award / grant (A) | Common Stock | 35,673 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Campion Suzanne | Award / grant (A) | Common Stock | 14,231 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Byers David Raynor | Tax withholding (F) | Common Stock | 924 | USD 8.67 | USD 8,011 | SEC filing ↗ |
| 2026-04-01 | Byers David Raynor | Award / grant (A) | Common Stock | 11,538 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Bulgarelli Peter J. | Award / grant (A) | Common Stock | 14,231 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | Bonick Martin | Tax withholding (F) | Common Stock | 10,952 | USD 8.67 | USD 94,954 | SEC filing ↗ |
| 2026-04-01 | Bonick Martin | Award / grant (A) | Common Stock | 134,615 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-01 | BYNOE PETER C B | Award / grant (A) | Common Stock | 14,231 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-11 | Petrovich Stephen C. | Award / grant (A) | Common Stock | 34,733 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-11 | LUMSDAINE ALFRED | Award / grant (A) | Common Stock | 61,081 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-11 | Chernin Ethan | Award / grant (A) | Common Stock | 32,408 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-11 | Byers David Raynor | Award / grant (A) | Common Stock | 8,859 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | ARDT |
| CIK | 0001756655 |
| Sector | Healthcare |
| Industry | Medical Care Facilities Yahoo Finance |
| SEC SIC | 8062 Services-General Medical & Surgical Hospitals, NEC |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 84 transaction lines from 2024-07-18 to 2026-09-25 4 P purchase lines · 0 S sale lines · 80 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.